UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

Network-based approach to prediction and population-based validation of in silico drug repurposing

Nature communications, 2018-07, Vol.9 (1), p.2691-12, Article 2691

2018

Volltextzugriff (PDF)

Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study

Arthritis & rheumatology (Hoboken, N.J.), 2019-06, Vol.71 (6), p.892-900

2019

Volltextzugriff (PDF)

Increase in prescription opioid use during pregnancy among Medicaid-enrolled women

Obstetrics and gynecology (New York. 1953), 2014-05, Vol.123 (5), p.997-1002

2014

Volltextzugriff (PDF)

Lithium Use in Pregnancy and the Risk of Cardiac Malformations

The New England journal of medicine, 2017-06, Vol.376 (23), p.2245-2254

2017

Volltextzugriff (PDF)

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn

JAMA : the journal of the American Medical Association, 2015-06, Vol.313 (21), p.2142

2015

Volltextzugriff (PDF)

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

JAMA psychiatry (Chicago, Ill.), 2016-09, Vol.73 (9), p.938

2016

Volltextzugriff (PDF)

Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study

BMJ (Online), 2017-08, Vol.358, p.j3326

2017

Volltextzugriff (PDF)

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout

PloS one, 2018-02, Vol.13 (2), p.e0193622-e0193622

2018

Volltextzugriff (PDF)

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims

PLoS medicine, 2019-03, Vol.16 (3), p.e1002763-e1002763

2019

Volltextzugriff (PDF)

External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure

PloS one, 2021-06, Vol.16 (6), p.e0252903-e0252903

2021

Volltextzugriff (PDF)

Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes

The American journal of psychiatry, 2018-06, Vol.175 (6), p.564-574

2018

Volltextzugriff (PDF)

Statin Lipophilicity and the Risk of Incident Heart Failure

Cardiology, 2020-06, Vol.145 (6), p.375-383

2020

Volltextzugriff (PDF)

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis

Arthritis research & therapy, 2017-07, Vol.19 (1), p.159-159, Article 159

2017

Volltextzugriff (PDF)

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease

Molecular psychiatry, 2023-03, Vol.28 (3), p.1312-1326

2023

Volltextzugriff (PDF)

Prospective validation of a dynamic prognostic model for identifying COVID‐19 patients at high risk of rapid deterioration

Pharmacoepidemiology and drug safety, 2023-05, Vol.32 (5), p.545-557

2023

Volltextzugriff (PDF)

Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study

Arthritis care & research (2010), 2020-10, Vol.72 (10), p.1383-1391

2020

Volltextzugriff (PDF)

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

Journal of the American Heart Association, 2018-02, Vol.7 (3), p.n/a

2018

Volltextzugriff (PDF)

Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure

Journal of the American Heart Association, 2023-07, Vol.12 (14), p.e029589-e029589

2023

Volltextzugriff (PDF)

Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data

PloS one, 2020-10, Vol.15 (10), p.e0241083

2020

Volltextzugriff (PDF)

Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All-Cause or Cardiovascular Mortality Using Administrative Claims

Journal of the American Heart Association, 2020-09, Vol.9 (17), p.e016906-e016906

2020

Volltextzugriff (PDF)

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study

Annals of the rheumatic diseases, 2022-06, Vol.81 (6), p.798

2022

Volltextzugriff (PDF)

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol

Journal of the American Heart Association, 2021-04, Vol.10 (7), p.e020045-e020045

2021

Volltextzugriff (PDF)

Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis

ACR open rheumatology, 2023-11, Vol.5 (11), p.571-580

2023

Volltextzugriff (PDF)

The Potential Return on Public Investment in Detecting Adverse Drug Effects

Medical care, 2017-06, Vol.55 (6), p.545-551

2017

Volltextzugriff (PDF)

Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework

NPJ digital medicine, 2021-12, Vol.4 (1), p.170-170, Article 170

2021

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Englisch
(219)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(166)
Life Sciences & Biomedicine
(158)
Humans
(125)
Female
(76)
Male
(54)
Cohort Studies
(49)
Aged
(48)
Adult
(42)
United States - Epidemiology
(36)
Middle Aged
(35)
Risk Factors
(33)
Rheumatology
(32)
Pharmacology & Pharmacy
(30)
Medicare
(28)
Patients
(28)
Public, Environmental & Occupational Health
(28)
United States
(28)
Pregnancy
(27)
General & Internal Medicine
(25)
Medicine, General & Internal
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Network-based approach to prediction and population-based validation of in silico drug repurposing

Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study

Increase in prescription opioid use during pregnancy among Medicaid-enrolled women

Lithium Use in Pregnancy and the Risk of Cardiac Malformations

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims

External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure

Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes

Statin Lipophilicity and the Risk of Incident Heart Failure

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease

Prospective validation of a dynamic prognostic model for identifying COVID‐19 patients at high risk of rapid deterioration

Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure

Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data

Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All-Cause or Cardiovascular Mortality Using Administrative Claims

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol

Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis

The Potential Return on Public Investment in Detecting Adverse Drug Effects

Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework

Suchergebnisse filtern